Research Priorities for Article 14-Demand Reduction Measures Concerning Tobacco Dependence and Cessation

Research Priorities for Article 14-Demand Reduction Measures Concerning Tobacco Dependence and Cessation

Autor McRobbie, Hayden Google Scholar
Raw, Martin Autor UNIFESP Google Scholar
Chan, Sophia Google Scholar
Instituição Univ Nottingham
Queen Mary Univ London
Sch Publ Hlth & Psychosocial Studies
Auckland Univ Technol
Universidade Federal de São Paulo (UNIFESP)
Univ Hong Kong
Resumo Introduction: Tobacco dependence treatment (TDT) interventions are often seen as expensive with little impact on the prevalence of tobacco use. However, activities that promote the cessation of tobacco use and support abstinence have an important role in any comprehensive tobacco control program and as such are recognized within Article 14 (A14) of the Framework Convention on Tobacco Control.Objectives: To review current evidence for TDT and recommend research priorities that will contribute to more people being helped to stop tobacco use.Methods: We used the recommendations within the A14 guidelines to guide a review of current evidence and best practice for promotion of tobacco cessation and TDT, identify gaps, and propose research priorities.Results: We identified nine areas for future research (a) understanding current tobacco use and the effect of policy on behavior, (b) promoting cessation of tobacco use, (c) implementation of TDT guidelines, (d) increasing training capacity, (e) enhancing population-based TDT interventions, (f) treatment for different types of tobacco use, (g) supply of low-cost pharmaceutical devices/products, (h) investigation use of nonpharmaceutical devices/products, and (i) refinement of current TDTs. Specific research topics are suggested within each of these areas and recognize the differences needed between high- and low-/middle-income countries.Conclusions: Research should be prioritized toward examining interventions that (a) promote cessation of tobacco use, (b) assist health care workers provide better help to smokers (e.g., through implementation of guidelines and training), (c) enhance population-based TDT interventions, and (d) assist people to cease the use of other tobacco products.
Idioma Inglês
Financiador National Cancer Institute
manufacturers of stop smoking medications
Johnson and Johnson
Número do financiamento National Cancer Institute: HHSN261201100185P
Data 2013-04-01
Publicado em Nicotine & Tobacco Research. Oxford: Oxford Univ Press, v. 15, n. 4, p. 805-816, 2013.
ISSN 1462-2203 (Sherpa/Romeo, fator de impacto)
Editor Oxford Univ Press
Extensão 805-816
Direito de acesso Acesso restrito
Tipo Resenha
Web of Science WOS:000316776700006

Mostrar registro completo

Arquivos deste item

Arquivos Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item aparece na(s) seguinte(s) coleção(s)